The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives.
1/5 보강
Acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children.
APA
Szoszkiewicz A, Światłowska A, et al. (2026). The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives.. Pharmacological reports : PR, 78(1), 27-44. https://doi.org/10.1007/s43440-025-00818-2
MLA
Szoszkiewicz A, et al.. "The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives.." Pharmacological reports : PR, vol. 78, no. 1, 2026, pp. 27-44.
PMID
41486341 ↗
Abstract 한글 요약
Acute lymphoblastic leukemia (ALL) is the most frequent malignancy in children. Although survival rates have improved in recent decades, relapse and therapy-related toxicities remain major challenges in pediatric ALL. Pharmacogenetics is an approach with the potential to refine precision medicine in pediatric ALL. This review synthesizes current knowledge on pharmacogenetic markers of drug efficacy, toxicity, and adverse effects for drugs used in childhood ALL, including glucocorticosteroids, vincristine, asparaginase, anthracyclines, 6-mercaptopurine, and methotrexate. Thiopurine methyltransferase (TPMT) and nudix hydrolase 15 (NUDT15) are the only pharmacogenetic markers with established clinical guidelines that inform thiopurine and methotrexate dosing. Insufficient and inconsistent evidence has limited the translation of most other pharmacogenetic findings into clinical practice. While most studies centered on coding variants, we also point to new approaches focusing on noncoding regions and epigenetic variation that hold promise for expanding the scope of clinically relevant biomarkers in the near future. Finally, we propose future research avenues, that could support the development of more individualized treatment strategies for children with ALL.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Novel roles of SETD2 in tumor metabolism and immunotherapy: a systematic review and meta-analysis.
- EZHIP in Pediatric Brain Tumors: From Epigenetic Mimicry to Therapeutic Vulnerabilities.
- EP300 promotes hepatocellular carcinoma proliferation, migration and in vivo tumorigenicity revealed by integrated experimental and bioinformatic analyses.
- Beyond XX and XY, Understanding Sex Differences in Leukemia.
- The lncRNA-DNA Methylation Axis in Hepatocellular Carcinoma: Mechanisms, Epigenetic Plasticity, and Biological Implications.
- Loss of Ezh2 promotes M2-like macrophage polarization in hepatocellular carcinoma.